DexCom, Inc. vs Trade Desk Inc — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while Trade Desk Inc trades at $13.54 (market cap $6.37B). The key difference: DexCom, Inc. is far larger — about 5.3× Trade Desk Inc's market cap, and DexCom, Inc. is trading nearer its 52-week high, Trade Desk Inc nearer its low. Which is the better fit depends on your goals.
| DXCM | TTD | |
|---|---|---|
Market Cap | $33.79B | $6.37B |
Sector | Health | Technology |
52-Week High | $89.53 | $55.36 |
52-Week Low | $54.84 | $13.39 |
Enterprise Value | $33.24B | $5.32B |
Trailing returns across standard periods
Latest headlines on both assets
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →The Trade Desk Inc is engaged in providing a technology platform for ad buyers. Through its cloud-based platform ad buyers can create, manage, and optimize data-driven digital advertising campaigns across ad formats and channels, including display, video, audio, in-app, native and social, on a multitude of devices. Its products include Data Management Platform, Cross-Device Targeting, Video Advertising, Mobile Advertising, and others.
Read more on TTD →